Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Norwich › NPI 1770593956
Hospital

Chenango Memorial Hospital INC

Chenango Memorial Hospital INC was paid $30.65M by Medicaid between Jan 2018 and Dec 2024, across 262 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.

33Billing provider infoCHENANGO MEMORIAL HOSPITAL INC
NORWICH, NY 13815
33aNPI1770593956assigned 08/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$30.65M
24GClaims433,815
24DCodes billed262
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#44 of 231
Median peer was paid$561K
This provider vs. median55×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,111$40K
201923,361$1.21M
202066,898$3.40M
202179,875$4.57M
202288,535$9.21M
202394,107$7.25M
2024incomplete78,928$4.97M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20% 43,860 39,649 $6.16M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 13,382 12,714 $3.12M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10.0% 21,590 19,533 $3.06M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.9% 7,038 6,816 $1.50M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4.0% 11,715 3,349 $1.21M
96361 Intravenous infusion, hydration; each additional hour 3.9% 3,231 2,932 $1.18M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.3% 5,628 5,386 $1.01M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.5% 4,918 4,882 $776K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.4% 5,202 4,823 $733K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.2% 4,863 4,858 $677K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.2% 3,814 3,653 $666K
80053 Comprehensive metabolic panel 2.1% 19,814 18,348 $653K
250 more codes
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.1% 2,980 $645K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.0% 1,292 $600K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 1,239 $519K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.7% 3,701 $519K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.6% 6,053 $497K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.5% 6,177 $473K
70450 Computed tomography, head or brain; without contrast material 1.4% 1,154 $437K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.0% 1,544 $315K
99204 Doctor's office visit, new patient (more involved) 1.0% 2,080 $315K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,961 $278K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 679 $276K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 1,922 $267K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,703 $246K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 482 $217K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,661 $217K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,200 $199K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,450 $196K
80061 Lipid panel <1% 6,579 $181K
97161 <1% 1,239 $148K
81025 <1% 3,738 $145K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 732 $127K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,365 $113K
20610 <1% 284 $102K
86900 <1% 1,479 $95K
90686 <1% 3,485 $93K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,670 $90K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,055 $81K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,479 $81K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 861 $80K
71046 Radiologic examination, chest; 2 views <1% 2,791 $72K
84443 Thyroid stimulating hormone (TSH) <1% 7,729 $71K
90648 <1% 3,295 $66K
90715 <1% 2,025 $62K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 19,220 $59K
90723 <1% 2,629 $57K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 498 $57K
90670 <1% 2,495 $52K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 371 $50K
90680 <1% 2,449 $49K
83655 <1% 2,697 $48K
36415 Collection of venous blood by venipuncture <1% 9,819 $48K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,944 $48K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 376 $48K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 567 $47K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 296 $44K
86850 <1% 1,464 $43K
90633 <1% 1,939 $42K
80048 Basic metabolic panel (calcium, ionized) <1% 1,505 $39K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,150 $39K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,327 $38K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,055 $37K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 461 $37K
72100 <1% 1,224 $34K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 526 $32K
81003 <1% 16,016 $31K
86703 <1% 1,757 $30K
83036 Hemoglobin; glycosylated (A1C) <1% 5,068 $29K
90734 <1% 894 $28K
76830 Ultrasound, transvaginal <1% 288 $27K
73630 <1% 1,142 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 211 $26K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 596 $26K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 250 $25K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 559 $25K
99215 Doctor's office visit, returning patient (complex) <1% 191 $25K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 127 $24K
90710 <1% 801 $22K
86901 <1% 1,507 $21K
87631 <1% 322 $21K
90716 <1% 814 $20K
77063 Screening digital breast tomosynthesis, bilateral <1% 993 $20K
90651 <1% 548 $19K
90707 <1% 799 $18K
D1110 Prophylaxis - adult <1% 316 $18K
87634 <1% 290 $18K
90700 <1% 769 $17K
90677 <1% 616 $17K
95117 <1% 307 $16K
96127 <1% 3,066 $15K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,202 $15K
87486 <1% 355 $15K
90696 <1% 694 $14K
73030 <1% 832 $14K
73610 <1% 902 $14K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,234 $14K
59025 Fetal non-stress test <1% 80 $14K
83880 <1% 366 $14K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 403 $14K
73130 <1% 910 $13K
82607 <1% 1,407 $13K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 115 $13K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 50 $13K
85027 <1% 3,507 $12K
90671 <1% 508 $12K
84439 <1% 2,142 $12K
84702 <1% 1,955 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,516 $11K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 221 $11K
D0120 Dental checkup, returning patient <1% 374 $11K
80306 <1% 2,901 $9K
85610 <1% 2,577 $9K
90656 <1% 378 $9K
73564 <1% 414 $8K
86803 <1% 1,513 $8K
87581 <1% 355 $8K
76801 <1% 75 $8K
99381 <1% 51 $8K
12001 <1% 13 $7K
93242 <1% 78 $7K
29125 <1% 28 $7K
76536 <1% 78 $7K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,392 $7K
73110 <1% 449 $6K
83735 <1% 3,306 $6K
82570 <1% 1,578 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 25 $6K
82043 <1% 1,403 $6K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 277 $6K
86618 <1% 784 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 73 $6K
36416 <1% 336 $5K
80050 General health panel <1% 36 $5K
72040 <1% 265 $5K
0012A <1% 161 $5K
86140 <1% 1,818 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 2,139 $4K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 30 $4K
86592 <1% 1,222 $4K
0011A <1% 170 $4K
D1120 Dental cleaning, child <1% 97 $4K
76641 <1% 49 $4K
87340 <1% 1,056 $4K
99441 <1% 95 $4K
76770 <1% 28 $4K
99442 <1% 72 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 389 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 25 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 396 $3K
86039 <1% 433 $3K
82728 <1% 285 $3K
71045 Radiologic examination, chest; single view <1% 2,500 $3K
84153 <1% 209 $3K
83550 <1% 446 $3K
G0378 Hospital observation service, per hour <1% 183 $3K
94060 <1% 12 $2K
83540 <1% 541 $2K
87081 <1% 804 $2K
72141 <1% 12 $2K
87400 <1% 1,952 $2K
11721 <1% 170 $2K
87070 <1% 1,546 $2K
86762 <1% 560 $2K
93017 <1% 13 $2K
92552 <1% 33 $2K
73502 <1% 113 $2K
86787 <1% 638 $2K
85652 <1% 1,357 $2K
74018 <1% 92 $2K
71250 <1% 12 $2K
90682 <1% 87 $2K
84436 <1% 284 $2K
D0274 Bitewings - four radiographic images <1% 55 $2K
96367 <1% 14 $2K
73562 <1% 121 $2K
87077 <1% 1,370 $1K
87186 <1% 1,351 $1K
83970 <1% 37 $1K
0064A <1% 35 $1K
85730 <1% 1,330 $1K
85014 <1% 297 $1K
82950 <1% 209 $1K
82150 <1% 1,442 $1K
83690 <1% 2,040 $1K
0001A <1% 25 $990.11
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 407 $971.72
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 28 $910.20
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 38 $814.58
83721 <1% 134 $807.03
93971 <1% 13 $787.94
85379 <1% 1,070 $749.02
84484 <1% 2,448 $716.46
85651 <1% 352 $664.76
84480 <1% 68 $657.53
80076 <1% 44 $567.55
82803 <1% 29 $541.62
87205 <1% 979 $522.50
86617 <1% 49 $469.55
87420 <1% 428 $459.66
85018 <1% 297 $422.24
0225U <1% 48 $416.78
82550 <1% 403 $401.99
72070 <1% 12 $341.46
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,395 $340.21
84703 <1% 406 $316.43
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 357 $286.09
73560 <1% 25 $249.54
80069 <1% 26 $243.64
G0008 Administration of influenza virus vaccine <1% 12 $242.70
84156 <1% 73 $221.84
86666 <1% 32 $217.93
90647 <1% 12 $215.28
90744 <1% 12 $214.20
82784 <1% 28 $204.60
86376 <1% 14 $189.15
86431 <1% 78 $186.02
86706 <1% 24 $170.73
D0220 Intraoral - periapical first radiographic image <1% 13 $168.00
86753 <1% 22 $151.21
Q3014 Telehealth originating site facility fee <1% 23 $128.31
87147 <1% 166 $114.52
73590 <1% 12 $78.39
82962 <1% 837 $77.60
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 13 $75.68
82948 <1% 137 $55.81
86308 <1% 25 $51.54
86430 <1% 14 $48.10
87040 <1% 201 $39.52
J7030 Infusion, normal saline solution , 1000 cc <1% 2,470 $38.83
84550 <1% 14 $31.78
83605 <1% 275 $21.15
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,217 $16.24
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,889 $13.64
C9113 Injection, pantoprazole sodium, per vial <1% 85 $11.37
J2704 Injection, propofol, 10 mg <1% 1,242 $7.08
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,817 $5.71
91322 <1% 15 $4.70
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 96 $4.04
90480 <1% 13 $2.73
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,977 $1.82
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 114 $1.06
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 15 $0.73
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 85 $0.53
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 251 $0.50
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 75 $0.36
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,690 $0.16
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 37 $0.14
J0690 Injection, cefazolin sodium, 500 mg <1% 248 $0.12
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,304 $0.06
90460 Immunization administration through 18 years of age via any route, first or only component 0% 75 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 12 $0.00
A4649 Surgical supply; miscellaneous 0% 87 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 465 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 239 $0.00
96376 0% 50 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 94 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 75 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 27 $0.00
94760 0% 15 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 18 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAMEN, DRAKE (PRESIDENT & CEO)
Same official

Other billing entities under LAMEN, DRAKE

Full network →
ProviderLocationPaid
Chenango Memorial Hospital, INC.Norwich, NY$6.33M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.